Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Current Deferred Revenue (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Current Deferred Revenue for 4 consecutive years, with $9000.0 as the latest value for Q3 2019.

  • Quarterly Current Deferred Revenue fell 75.0% to $9000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $9000.0 through Sep 2019, down 75.0% year-over-year, with the annual reading at $36000.0 for FY2018, 0.0% changed from the prior year.
  • Current Deferred Revenue for Q3 2019 was $9000.0 at Forte Biosciences, down from $18000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $1.0 million in Q2 2018, with the low at $9000.0 in Q3 2019.
  • Average Current Deferred Revenue over 4 years is $116833.3, with a median of $36000.0 recorded in 2017.
  • The sharpest move saw Current Deferred Revenue skyrocketed 2426.83% in 2018, then tumbled 98.26% in 2019.
  • Over 4 years, Current Deferred Revenue stood at $45000.0 in 2016, then dropped by 20.0% to $36000.0 in 2017, then changed by 0.0% to $36000.0 in 2018, then tumbled by 75.0% to $9000.0 in 2019.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $9000.0, $18000.0, and $27000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.